Delivery Order SPE2DB25D7067-SPE2DB25FSVDP
- Not listed
- The Defense Logistics Agency awarded a $1,233.66 delivery order to AmerisourceBergen Drug Corp for MOVIPREP powder packets on September 22, 2025, with an ultimate completion date of September 23, 2025. This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (Contract No. SPE2DX15D1021|SPE2DX24FHQUK) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,956,715 units of MOVIPREP Powder Packets. The delivery order has a ceiling value of $1,068.90 and a period of performance through March 14, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver these...
- The Defense Logistics Agency awarded a delivery order valued at $1,165.02 to AmerisourceBergen Drug Corp for MOVIPREP powder packets, with a completion date of September 30, 2025. This firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026. The award was made on a competitive basis with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of MOVIPREP powder packets, a bowel preparation medication, with a ceiling value of $1,233.66. This firm fixed-price contract, executed without a set-aside designation, represents a competitively awarded delivery order under the company's existing pharmaceutical supply agreement with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,828,006 units of MOVIPREP POWDER PACKETS, a pharmaceutical product, at a firm fixed price of $2,807.92. The order has an ultimate completion date of September 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, with a potential value of $1,413.76, is for the provision of MOVIPREP POWDER PACKETS to be delivered by February 9, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $15,620.25 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA to provide a range of...
- This is a delivery order (SPE2DB25FEHR9) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOVIPREP powder packets. The contract has a firm fixed price and a ceiling value of $1,609.09. It was awarded on April 14, 2025, with an ultimate completion date of April 15, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a wholly owned subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the supply of MOVIPREP POWDER PACKETS, a pharmaceutical product, with a potential value of $3,467.31 and a completion date of March 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,548.58, is for the supply of MOVIPREP POWDER PACKETS, a medical product, with a period of performance ending on April 24, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support...
- SPE2DB25D7067Indefinite Delivery Contract
- SPE2DB25D7067-SPE2DB25FSVDPDelivery Order
The Defense Logistics Agency awarded a $2,362.20 delivery order to AmerisourceBergen Drug Corp for MOVIPREP powder packets on June 2, 2025, with completion expected by June 3, 2025. This competitive award, issued under firm fixed pricing terms with no set-aside designation, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. MOVIPREP is a bowel preparation solution commonly used in medical settings for gastrointestinal procedures. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. The company's extensive federal contracting history demonstrates consistent capability to fulfill competitive pharmaceutical procurement requirements across multiple therapeutic domains and delivery scales.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 6/2/25 |